OTCBB:FNAM

Evolutionary Genomics Stock Insider Trading

etoro logo Buy FNAM
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Jun 03, 2026

Evolutionary Genomics Stock Insider Power

Based on the 72 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 23.39M and sold 13.31M FNAM shares in the last 72 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 72 transactions)
0
Buy 23.39M shares
Sell 13.31M shares
69% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Oct 19, 2015
Buy
Options
Orndorff Virginia P.
Director
Director 20 000
Value: $11.0K
Oct 19, 2015
Buy
Common Stock
Boggess Mark Virgil
Director
Director 0
Value: $0
Oct 01, 2014
Sell
Common Stock
S-Sale
Schwartz Sanford
Insider
Other 1 530 901
Value: $32.1K
Oct 01, 2014
Sell
Common Stock
S-Sale
Friess Michael
Insider
Other 1 530 901
Value: $32.1K
Oct 01, 2014
Sell
Common Stock
S-Sale
Schwartz Sanford
Insider
Other 1 530 901
Value: $32.1K
Oct 01, 2014
Sell
Common Stock
S-Sale
Friess Michael
Insider
Other 1 530 901
Value: $32.1K
Oct 01, 2014
Buy
Common Stock
A-Award
Warnecke Steve B
CFO/secretary/treasurer
C-Suite Officer 5 201 423
Value: $109.2K
Oct 01, 2014
Sell
Call Option
D-Return
Warnecke Steve B
CFO/secretary/treasurer
C-Suite Officer 3 222 950
Value: $0
Oct 01, 2014
Buy
Common Stock
A-Award
Warnecke Steve B
CFO/secretary/treasurer
C-Suite Officer 5 201 423
Value: $109.2K
Oct 01, 2014
Sell
Call Option
D-Return
Warnecke Steve B
CFO/secretary/treasurer
C-Suite Officer 3 222 950
Value: $0
Jun 16, 2014
Buy
Call Option (right to buy)
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 3 222 950
Value: $10K
Jun 16, 2014
Buy
Common Stock
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 0
Value: $0
Jun 16, 2014
Buy
Common Stock
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 0
Value: $0
Jun 16, 2014
Buy
Call Option (right to buy)
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 2 252 233
Value: $20.3K
Jun 16, 2014
Buy
Call Option (right to buy)
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 2 252 233
Value: $20.3K
Jun 16, 2014
Buy
Call Option (right to buy)
Warnecke Steve B
Chief Financial Officer, Tsd
C-Suite Officer 3 222 950
Value: $10K
Nov 23, 2010
Buy
Common Stock
Friess Michael
President/ceo
CEO / President 0
Value: $0
Nov 23, 2010
Buy
Common Stock
Schwartz Sanford
Director 0
Value: $0
Nov 23, 2010
Buy
Common Stock
Divita Chloe M
Secretary/treasurer/cfo
C-Suite Officer 0
Value: $0
Nov 23, 2010
Buy
Common Stock
Friess Michael
President/ceo
CEO / President 0
Value: $0
Nov 23, 2010
Buy
Common Stock
Divita Chloe M
Secretary/treasurer/cfo
C-Suite Officer 0
Value: $0
Nov 23, 2010
Buy
Common Stock
Schwartz Sanford
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EVOLUTIONARY GENOMICS, INC.
Evolutionary Genomics
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and com...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE